Quest Diagnostics 2012 Annual Report Download - page 23

Download and view the complete annual report

Please find page 23 of the 2012 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 126

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126

20
AVAILABLE INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the Securities and Exchange
Commission (the “SEC”). You may read and copy any document that we file with the SEC at the SEC's public reference room
at 100 F Street, NE, Washington, DC 20549. Please call the SEC at 1-800-SEC-0330 for information regarding the public
reference room. The SEC maintains an internet site that contains annual, quarterly and current reports, proxy and information
statements and other information that issuers (including Quest Diagnostics) file electronically with the SEC. Our electronic
SEC filings are available to the public at the SEC's internet site, www.sec.gov.
Our internet site is www.QuestDiagnostics.com. You can access Quest Diagnostics' Investor Relations webpage at
www.QuestDiagnostics.com/investor. The information on our website is not incorporated by reference into this Report. We
make available free of charge, on or through our Investor Relations webpage, our proxy statements, Annual Report on Form 10-
K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports filed or furnished
pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as soon as reasonably practical after such
material is filed with, or furnished to, the SEC. We also make available, through our Investor Relations webpage, statements of
beneficial ownership of our equity securities filed by our directors, officers and others under Section 16 of the Exchange Act.
We have a corporate governance webpage. You can access information regarding our corporate governance at
www.QuestDiagnostics.com/governance. We post the following on our corporate governance webpage:
• Directors
• Management
• Code of Business Ethics
• Integrity Commitment
• Values
• Corporate Governance Guidelines
• Charters for the following committees of our Board of Directors: Audit and Finance; Compensation; Executive;
Governance; and Quality, Safety and Compliance
• Certificate of Incorporation
• Bylaws
EXECUTIVE OFFICERS OF THE COMPANY
The following persons serve as executive officers of the Company.
Stephen H. Rusckowski (55) is President and Chief Executive Officer. Prior to joining the Company in May 2012,
since October 2006, he was Chief Executive Officer of Philips Healthcare, the largest unit of Royal Philips Electronics, and a
member of the Board of Management of Royal Philips Electronics and its Executive Committee. Previously, he was CEO of
the Imaging Systems business within Royal Phillips Electronics. Before joining Philips in 2001, Mr. Rusckowski held
numerous management positions with the healthcare division of Hewlett-Packard/Agilent Technologies. Mr. Rusckowski has
been a director of the Company since May 2012.
Jon R. Cohen, M.D. (58) is Senior Vice President and Chief Medical Officer. Dr. Cohen joined the company in March
2009 and served as Chief Medical Officer. From May 2011 to January 2013, he also had responsibility for Hospital Services.
In January 2013, Dr. Cohen also assumed responsibility in the Company's Diagnostic Information Services business for cancer
diagnostic solutions and hospital professional services. He served as the Senior Advisor to New York Governor David
Patterson from 2008 to 2009, where he was responsible for all policy and strategic planning. From 2007 to 2008, Dr. Cohen
was a managing director, health industries advisory services at PricewaterhouseCoopers LLP. Prior to that, he spent 21 years
with North Shore-Long Island Jewish Health System, one of the nation's largest not-for-profit health systems, including serving
as its Chief Medical Officer from 2000 to 2006.
Everett V. Cunningham (46) is Senior Vice President, Commercial. Mr. Cunningham is responsible for the commercial
organization for the Company's Diagnostic Information Services business. Mr. Cunningham joined the Company October 2012.
Previously, Mr. Cunningham was with Pfizer, Inc., where he served in a series of sales and leadership and general management
roles for 21 years. From June 2011 to October 2012, he served as Regional President, Established Products, Asia. From 2009
to 2011, Mr. Cunningham served as Regional President, West Business Unit, Primary Care. From 2007 to 2009, he served as
Vice President, Human Resources, Corporate Groups. From 2003 to 2007, Mr. Cunningham was Vice President, Sales, U.S.
Pharmaceuticals, Pain and Musculoskeletal Division.